| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/19/2015 | US20150051145 Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders |
| 02/19/2015 | US20150051144 Compounds for the treatment of dyslipidemia and other diseases |
| 02/19/2015 | US20150051143 Compositions and methods for treating non-alcoholic steatohepatitis |
| 02/19/2015 | US20150050620 Preventing or treating periodontal disease |
| 02/19/2015 | US20150050499 Fibrosis causing agent |
| 02/19/2015 | US20150050497 Nicotinamide powder and process and device for its production |
| 02/19/2015 | US20150050375 Total flavone extract of flower of abelmoschus manihot l. medic and preparation method thereof |
| 02/19/2015 | US20150050374 Supplement composition and methods of use |
| 02/19/2015 | US20150050368 Method for producing a plant extract from desmodium and its extract thereof |
| 02/19/2015 | US20150050367 Timosaponin compounds |
| 02/19/2015 | US20150050362 Essential Oil of Kunzea Ambigua and Methods of Use |
| 02/19/2015 | US20150050361 Topically administered strontium-containing complexes for treating pain, pruritis and inflammation |
| 02/19/2015 | US20150050360 Pharmaceutical compositions for treating cancer |
| 02/19/2015 | US20150050357 Nanoparticle isoflavone compositions & methods of making and using the same |
| 02/19/2015 | US20150050356 Nanoparticle comprising rapamycin and albumin as anticancer agent |
| 02/19/2015 | US20150050355 Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof |
| 02/19/2015 | US20150050347 Reverse micelle system comprising nucleic acids and use thereof |
| 02/19/2015 | US20150050346 Compositions and methods for treating insulin resistance and diabetes mellitus |
| 02/19/2015 | US20150050345 Methods for fine particle manufacture |
| 02/19/2015 | US20150050343 Methods of wound care and treatment |
| 02/19/2015 | US20150050342 Compositions for treatment of skin disorders |
| 02/19/2015 | US20150050340 Sustained-release drug carrier composition |
| 02/19/2015 | US20150050339 Phenylethanoic Acid, Phenylpropanoic Acid and Phenylpropenoic Acid Conjugates and Prodrugs of Hydrocodone, Method of Making and Use Thereof |
| 02/19/2015 | US20150050338 Method for treatment of diarrhea-predominant irritable bowel syndrome |
| 02/19/2015 | US20150050337 Extended Release Compositions |
| 02/19/2015 | US20150050336 Taste Masking System For Non-Plasticizing Drugs |
| 02/19/2015 | US20150050335 Extended Release Pharmaceutical Formulations of Water-Soluble Active Pharmaceutical Ingredients and Methods for Making the Same |
| 02/19/2015 | US20150050333 Pharmaceutical composition comprising olmesartan medoxomil and rosuvastatin or its salt |
| 02/19/2015 | US20150050330 Compositions and methods for polymer-caged liposomes |
| 02/19/2015 | US20150050329 Liposomal corticosteroids for treatment of inflammatory disorders in humans |
| 02/19/2015 | US20150050325 Organic compounds |
| 02/19/2015 | US20150050313 Novel immunostimulants and synthesis thereof |
| 02/19/2015 | US20150050299 Methods for enhancing immune response |
| 02/19/2015 | US20150050295 Novel lipids and compositions for intracellular delivery of biologically active compounds |
| 02/19/2015 | US20150050294 Methods for diagnosing and treating neuroendocrine cancer |
| 02/19/2015 | US20150050289 Muscle specific receptor kinase and modulation thereof |
| 02/19/2015 | US20150050288 Treatment of TH17-Mediated Autoimmune Disease Via Inhibition of Stat3 |
| 02/19/2015 | US20150050285 Combination Therapy for Cancer Using HSP27 Inhibitor and EGFR Tyrosine Kinase Inhibitors or Anti-Folates |
| 02/19/2015 | US20150050277 Compositions and methods for treating ocular diseases |
| 02/19/2015 | US20150050263 Novel Compounds For Preventing And/Or Treating Lysosomal Storage Disorders And/Or Degenerative Disorders Of The Central Nervous System |
| 02/19/2015 | US20150050261 Dietary and nutritional supplements containing an omega-3 fatty acid of plant-based origin and a folate derivative |
| 02/19/2015 | US20150050260 Pyrroloquinoline quinone based compositions and uses |
| 02/19/2015 | US20150050259 Nutraceutical modulators of stem cell activity |
| 02/19/2015 | US20150050257 Fibrosis causing agent |
| 02/19/2015 | US20150050241 Method of treating viral infections |
| 02/19/2015 | US20150050240 Treatment of fibrosis |
| 02/19/2015 | US20150050239 Substituted pyrazolone compounds and methods of use |
| 02/19/2015 | US20150050237 New anti-mycobacterial drugs against tuberculosis |
| 02/19/2015 | US20150050226 Therapeutic vitamin d sun-protecting formulations and methods for their use |
| 02/19/2015 | US20150050219 Coloured solution in particular for use in surgical methods for the treatment of the bodies of humans or animals |
| 02/19/2015 | US20150050210 Pharmaceutical formulation comprising bendamustine |
| 02/19/2015 | DE102014113485A1 Kosmetische Zusammensetzung und deren Verwendung zur Prophylaxe und Behandlung von Hautunreinheiten, zu Akne neigender Haut und Akne Cosmetic composition and its use for the prophylaxis and treatment of skin blemishes, acne-prone skin and acne |
| 02/19/2015 | DE102013114672A1 Metallo-Acylhydrazon-Komplexe und ihre Verwendung zur Vermeidung der Ausbildung oder zur Aufhebung von Resistenzen von Tumoren gegen Zytostatika sowie zur Behandlung von Tumoren (Antitumormittel) Metallo-acylhydrazone complexes and their use to avoid the formation or to the annulment of resistance of tumors to cytotoxic drugs and for the treatment of tumors (anti-tumor agent) |
| 02/19/2015 | DE102013013796A1 Stoffgemische enthaltend Vitamin B12 zur spezifischen Anwendung für die Behandlung des Raynaud-Syndroms Mixtures comprising vitamin B12 for the specific application for the treatment of Raynaud's syndrome |
| 02/18/2015 | EP2837632A1 Compound jk12a and preparation thereof |
| 02/18/2015 | EP2837631A1 New stable salt of 5,10-methylene-(6R)-tetrahydrofolic acid |
| 02/18/2015 | EP2837627A1 Amidopyridine derivative, and use thereof |
| 02/18/2015 | EP2837623A1 Novel 1-substituted indazole derivative |
| 02/18/2015 | EP2837620A1 Aryloxyurea compound and pest control agent |
| 02/18/2015 | EP2837390A1 Combined Pharmaceutical Preparation for Use in Treating Neuromuscular Disorders |
| 02/18/2015 | EP2837389A1 Medicinal composition for treating infarction |
| 02/18/2015 | EP2837384A1 Glutathione based delivery system |
| 02/18/2015 | EP2837382A1 Composition comprising purine derivatives or salt thereof for preventing or treating atopic dermatitis |
| 02/18/2015 | EP2837381A1 Use of agents that alter the peritumoral environment for the treatment of cancer |
| 02/18/2015 | EP2837380A1 Lercanidipine hydrochloride and losartan potassium compound preparation and preparation method thereof |
| 02/18/2015 | EP2837379A1 Dosage form comprising a 5-alpha-reductase steroid inhibitor and an alpha blocker, process for the preparation of a dosage form, use of dosage form, method for the treatment or prophylaxis of a disease or condition mediated by androgen |
| 02/18/2015 | EP2837378A1 Pharmaceutical compositions of rifaximin |
| 02/18/2015 | EP2837376A2 Compacted moxifloxacin |
| 02/18/2015 | EP2837373A1 Novel hyaluronic acid decomposition-promoting factor and inhibitor thereof |
| 02/18/2015 | EP2836596A2 Compositions for controlling varroa mites in bees |
| 02/18/2015 | EP2836595A2 Compositions and methods for inhibiting expression of the alas1 gene |
| 02/18/2015 | EP2836514A1 Tiki inhibitors |
| 02/18/2015 | EP2836501A1 Rna aptamers for therapeutic and diagnostic delivery to pancreatic cancer cells |
| 02/18/2015 | EP2836500A1 Process for preparation of benzylbenzene sodium-dependent glucose cotransporter 2 (sglt2) inhibitors |
| 02/18/2015 | EP2836499A1 Disaccharide synthetic lipid compounds and uses thereof |
| 02/18/2015 | EP2836495A1 Tetrahydropyrrolothiazine compounds |
| 02/18/2015 | EP2836494A1 New alkylating agents |
| 02/18/2015 | EP2836493A1 Functionalized thieno-indole derivatives for the treatment of cancer |
| 02/18/2015 | EP2836492A1 Substituted xanthine derivatives |
| 02/18/2015 | EP2836491A1 Salt form of a human hi stone methyltransf erase ezh2 inhibitor |
| 02/18/2015 | EP2836490A2 Indole and indazole compounds that activate ampk |
| 02/18/2015 | EP2836487A1 Heterocyclic compounds and uses thereof |
| 02/18/2015 | EP2836486A1 Diaminopyrimidines useful as inhibitors of the human respiratory syncytial virus (rsv) |
| 02/18/2015 | EP2836485A1 Conformationally constrained, fully synthetic macrocyclic compounds |
| 02/18/2015 | EP2836483A1 Anti-malarial agents |
| 02/18/2015 | EP2836482A1 Compositions and methods for treating cancer |
| 02/18/2015 | EP2836481A1 Methods and compositions for treating ewings sarcoma family of tumors |
| 02/18/2015 | EP2836478A2 Coriolus versicolor extracts, methods of isolating biologically-active compounds, and uses thereof |
| 02/18/2015 | EP2836240A1 Compositions and methods for treating otitis media and other conditions with inhibitors of cyld |
| 02/18/2015 | EP2836238A1 Co-polymer conjugates |
| 02/18/2015 | EP2836228A1 Combination of somatostatin-analogs with 11beta-hydroxylase inhibitors |
| 02/18/2015 | EP2836221A2 Method of using cyclodextrin |
| 02/18/2015 | EP2836220A1 Methods for bladder cancer therapy using baculoviral vectors |
| 02/18/2015 | EP2836219A1 Methods for the treatment of nonalcoholic steatohepatitis |
| 02/18/2015 | EP2836218A1 Prebiotic compositions and methods of use |
| 02/18/2015 | EP2836217A1 Compositions and methods for treatment of the side-effects associated with administration of cancer chemotherapeutic agents |
| 02/18/2015 | EP2836216A1 Combination therapy for treating cancer |
| 02/18/2015 | EP2836215A1 Composition for prevention of vasoactivity in the treatment of blood loss and anemia |
| 02/18/2015 | EP2836214A1 Bruton's tyrosine kinase inhibitors for hematopoietic mobilization |
| 02/18/2015 | EP2836213A1 Organic compounds |